Published in Transfusion on May 13, 2011
Why is saline so acidic (and does it really matter?). Int J Med Sci (2013) 0.92
In vitro investigation of the effect of plasticizers on the blood compatibility of medical grade plasticized poly (vinyl chloride). J Mater Sci Mater Med (2013) 0.78
Plasticizer concentration in cord blood cryopreserved with DMSO. Bone Marrow Transplant (2013) 0.75
Leaching of phthalate esters from different drinking stuffs and their subsequent biodegradation. Environ Sci Pollut Res Int (2017) 0.75
Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med (2010) 5.23
Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA (2008) 2.65
The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion (2009) 2.56
A novel mouse model of red blood cell storage and posttransfusion in vivo survival. Transfusion (2009) 2.26
Blood donors and factors impacting the blood donation decision. Transfus Med Rev (2002) 2.25
Noninfectious serious hazards of transfusion. Anesth Analg (2009) 2.21
Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion (2009) 2.04
The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006. Transfusion (2008) 1.77
Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood (2005) 1.77
HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer (2010) 1.63
Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion (2006) 1.62
Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood (2007) 1.55
Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus Med Rev (2007) 1.40
ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. Transfus Apher Sci (2010) 1.32
CMV DNA is rarely detected in healthy blood donors using validated PCR assays. Transfusion (2003) 1.23
Do red cell transfusions increase the risk of necrotizing enterocolitis in premature infants? J Pediatr (2010) 1.10
Transfusion-related acute lung injury: from bedside to bench and back. Blood (2010) 1.08
Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion (2010) 1.04
Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index. J Infect Dis (2010) 1.03
Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis. Transfusion (2007) 1.01
Minority and foreign-born representation among US blood donors: demographics and donation frequency for 2006. Transfusion (2009) 1.01
Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics (2009) 1.01
Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen. Transfusion (2009) 1.00
Racial differences in motivators and barriers to blood donation among blood donors. Arch Pathol Lab Med (2009) 0.99
Exchange transfusion for malaria and Babesia infection. Transfus Med Rev (2002) 0.97
Prevalence of selected viral infections among blood donors deferred for potential risk to blood safety. Transfusion (2006) 0.96
The potential impact of selective donor deferrals based on estimated blood volume on vasovagal reactions and donor deferral rates. Transfusion (2010) 0.95
Pathophysiology of early trauma-induced coagulopathy: emerging evidence for hemodilution and coagulation factor depletion. J Trauma (2011) 0.95
Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells. Transfusion (2008) 0.95
Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions. Transfus Med Rev (2011) 0.93
An automatable format for accurate immunohematology testing by flow cytometry. Transfusion (2003) 0.91
Blood donation and blood transfusion: special considerations for African Americans. Transfus Med Rev (2008) 0.91
The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Transfusion (2009) 0.91
Transfusion management of trauma patients. Anesth Analg (2009) 0.90
Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes. Blood (2007) 0.90
Motivators and barriers to blood donation in African American college students. Transfus Apher Sci (2009) 0.89
Demographic patterns of blood donors and donations in a large metropolitan area. J Natl Med Assoc (2011) 0.88
Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A. Transfusion (2007) 0.87
Unappreciated risk factors for transplant patients: HLA antibodies in blood components. Hum Immunol (2004) 0.87
Minority donation in the United States: challenges and needs. Curr Opin Hematol (2010) 0.86
Blood donations motivators and barriers: a descriptive study of African American and white voters. Transfus Apher Sci (2012) 0.86
Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation. J Immunol (2003) 0.86
Demographic differences in estimated blood donor eligibility prevalence in the United States. Transfusion (2011) 0.84
Leukoreduction filtration of blood with sickle cell trait. Transfus Med Rev (2004) 0.84
Granulocyte transfusion: revisited. Curr Hematol Rep (2003) 0.83
Contribution of attitudinal factors to blood donation in African American church attendees. Transfusion (2010) 0.83
Improved method for fluorescence cytometric immunohematology testing. Transfusion (2004) 0.82
Transfusion-related acute lung injury. Hematol Oncol Clin North Am (2007) 0.82
Critical evaluation of informed consent forms for adult and minor aged whole blood donation used by United States blood centers. Transfusion (2009) 0.81
Animal models of transfusion-related acute lung injury. Transfus Med Rev (2009) 0.80
Effect of mediators of innate immunity and inflammation on CD8+ veto cells. Transplantation (2004) 0.80
Islet transplantation, stem cells, and transfusion medicine. Transfus Med Rev (2003) 0.80
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Transfusion (2010) 0.80
Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant (2005) 0.79
Donor lymphocyte infusion therapy. Transfus Med Rev (2002) 0.79
Effects of storage duration and volume on the quality of leukoreduced apheresis-derived platelets: implications for pediatric transfusion medicine. Transfusion (2010) 0.78
Is there transfusion-related acute renal injury? Anesthesiology (2010) 0.78
The value of area-based analyses of donation patterns for recruitment strategies. Transfusion (2014) 0.78
Spotlight on pathogenesis of TRALI: HNA-3a (CTL2) antibodies. Blood (2014) 0.78
Evaluating a program to increase blood donation among racial and ethnic minority communities in New York City. Transfusion (2014) 0.78
Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor. Transfusion (2009) 0.77
Transfusion-transmitted cytomegalovirus: lessons from a murine model. Transfus Med Rev (2007) 0.77
Transfusion-transmitted cytomegalovirus (CMV) infections in a murine model: characterization of CMV-infected donor mice. Transfusion (2006) 0.76
Residual risk of D alloimmunization: is it time to feel safe about platelets from D+ donors? Transfusion (2011) 0.76
Ex vivo generated red cells as transfusion products. Stem Cells Int (2012) 0.76
Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model. Transfusion (2004) 0.76
Consensus recommendations of pediatric transfusion medicine objectives for clinical pathology residency training programs. Transfusion (2009) 0.75
Cardiovascular disease risk assessment and prevention in blood donors. Transfusion (2012) 0.75
Procedure-specific preoperative red blood cell preparation and utilization management in pediatric surgical patients. Transfusion (2009) 0.75
Transfusion medicine as a profession: evolution over the past 50 years. Transfusion (2010) 0.75
The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention. Transfus Apher Sci (2013) 0.75
Transfusion medicine illustrated. Detection of mixed-field agglutination due to loss of red cell antigen in hematopoietic malignancy. Transfusion (2006) 0.75
Comparison of cytomegalovirus polymerase chain reaction and serology for screening umbilical cord blood components. Transfusion (2005) 0.75
Evaluating the role of blood collection centers in public health: a status report. Transfus Med Rev (2011) 0.75
Tissue oversight in hospitals: the role of the transfusion services. Transfusion (2007) 0.75
Patient blood management: key for accountable care organizations. JAMA Surg (2013) 0.75
CD36 immunization in a patient undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer (2008) 0.75